SARAH APARECE: Open Payments
NPI 1093308033 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,222 in 48 payments from 14 companies in 2025. Trend: 2023 $1,595 · 2024 $2,001 · 2025 $2,222
Food & beverage: $1,942Education: $280
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 7 | $445 |
| Incyte Corporation | 7 | $381 |
| Astellas Pharma US Inc | 7 | $292 |
| Syndax Pharmaceuticals, Inc. | 6 | $282 |
| AstraZeneca Pharmaceuticals LP | 5 | $256 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 3 | $94 |
| Lilly USA, LLC | 3 | $75 |
| ABBVIE INC. | 2 | $66 |
| Merck Sharp & Dohme LLC | 2 | $62 |
Products named: JAKAFI, CALQUENCE, Vonjo, Cresemba, REVUFORJ, OJJAARA, SCEMBLIX, REBLOZYL.
Industry payments across TX — which companies pay providers there.
